Insights on Lipomatosis after Platinum-Based Chemotherapy Use in Pediatric Oncology: A Case Report

• Published in: Medicina (Kaunas, Lithuania) Vol. 58; no. 12; p. 1715
• Main Authors: Boeriu, Estera, Boc, Alexandra Georgiana, Borda, Alexandra, Negrean, Rodica Anamaria, Feciche, Bogdan, Boeriu, Amalia Iulia, Horhat, Florin George, Mot, Ion Cristian, Horhat, Ioana Delia, Ravulapalli, Madhavi, Sabuni, Omar, Adi, Abduljabar, Anjary, Adnan, Arghirescu, Smaranda Teodora
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 23.11.2022; MDPI
• Subjects: Abdomen; Ascites; Asymptomatic; Biomarkers; Bone cancer; Brain cancer; Calcification; Cancer; Care and treatment; Case Report; Case reports; Cellular biology; Chemotherapy; Child; Children; cisplatin; Cisplatin - adverse effects; Connective tissue tumors; Diagnosis; germ cell tumors; Health aspects; Humans; Investigations; Laparotomy; Lipoma - drug therapy; lipomatosis; Lipomatosis - drug therapy; Liver Neoplasms - drug therapy; Metabolism; Metastasis; Neoplasms, Germ Cell and Embryonal; Obesity; Ovaries; Pathology; Patient outcomes; pediatric oncology; Pediatrics; Platinum; Platinum - therapeutic use; platinum-based chemotherapy; Pleural effusion; Sarcoma; Surgery; Tumors; Turkey; platinum-based chemotherapy; germ cell tumors; lipomatosis; pediatric oncology; cisplatin
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina58121715

Agents of platinum-based chemotherapy, such as cisplatin or carboplatin, are used in the treatment of a wide range of malignancies that affect children, such as brain tumors, osteosarcoma, neuroblastoma, hepatoblastoma, and germ cell tumors (GCTs). The Cyclophosphamide Equivalent Dose (CED) calculator for reproductive risk does not take platinum-based chemotherapy into account, despite the fact that it accounts for the majority of chemotherapy medications that are typically administered for pediatric GCTs. As a result, exposure to platinum-based drugs throughout infancy can have predictable long-term effects such as infertility, as well as other rare encounters such as lipoma formation and lipomatosis. Lipomas are the most prevalent benign soft tissue tumor subtype. They may be either solitary entities or engaged in multiple lipomatosis, which may have a familial origin or be an acquired disorder. Chemotherapy is a possible cause of lipomatosis. Chemotherapy based on cisplatin has been linked to a variety of long-term consequences, including kidney damage, neurotoxicity, and pulmonary toxicity, and may even create secondary cancers. However, lipoma development is known to occur in fewer than 1 in 100 individuals, and only a few examples of multiple cutaneous lipomatosis triggered by this therapy have been documented. Here we present a very rare case of lipomatosis in a pediatric patient with GCT under cisplatin therapy, which might be the third report of this kind affecting children.